谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
Linong Ji, Hongwei Jiang,Yan Bi, Hua Li, Junhang Tian, Dexue Liu, Yuzhu Zhao, Wei Qiu, Chongbing Huang, Lei Chen,Shao Zhong, Jie Han, Yawei Zhang,Qiufang Lian, Ping Yang, Lingchun Lv, Jieyu Gu, Zihan Liu,Huan Deng, Yanqi Wang, Li, Lijuan Pei, Lei Qian, GLORY-1 Investigators
The New England journal of medicineno. 22 (2025): 2215-2225
引用0浏览0WOS引用
0
0
Efficacy and Safety of Mazdutide in Chinese Participants with Overweight or Obesity (GLORY-1)
L. Ji, H. Jiang, H. Li,J. Tian, D. Liu, Y. Zhao, W. Qiu,Y. Bi, J. Gu, Z. Liu,H. Deng, Y. Wang, L. Li, L. Qian
DIABETOLOGIA (2024): S81-S82
引用0浏览0引用
0
0
Improvement of Liver Steatosis by Mazdutide in Chinese Participants with Overweight or Obesity-An Exploratory Analysis of GLORY-1
L. Gao,L. Ji, H. Jiang, Y. Zhang, L. Lv, J. Gu, Z. Liu,H. Deng,Y. Wang, L. Qian
DIABETOLOGIA (2024): S356-S357
引用0浏览0引用
0
0
A Phase 2 Study of Mazdutide 9 Mg in Chinese Adults with BMI≥30 Kg/m2
H. Jiang,L. Ji, Y. Zhang,Z. Cheng,S. Pang,X. Li, W. Qiu, Q. Ma, Z. Liu, Y. Wang,H. Deng, L. Qian
DIABETOLOGIA (2024): S351-S352
引用0浏览0引用
0
0
1857-LB: Improvement of Liver Steatosis by Mazdutide in Chinese Participants with Overweight or Obesity—An Exploratory Analysis of GLORY-1
LINONG JI, HONGWEI JIANG,YAWEI ZHANG, LINGCHUN LV, JIEYU GU, ZIHAN LIU, YANQI WANG,HUAN DENG, LEI QIAN
Diabetesno. Supplement_1 (2024)
引用0浏览0引用
0
0
Mazdutide Vs Dulaglutide in Patients with Type 2 Diabetes (DREAMS-2): a Randomised, Open-Label, 28-Week Phase 3 Trial
L. Guo, W. Yang, X. Dong, X. Zhang, H. Cai, H. Jiang, L. Zhang, P. Jin, X. Wang, H. Hu, F. Xue, L. Li,H. Deng
DIABETOLOGIA (2024): S516-S517
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 22

#Citation: 159

H-Index: 7

G-Index: 11

Sociability: 5

Diversity: 2

Activity: 28

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn